Independent Medical Review Service Market Report 2026

The independent medical review service market size has grown rapidly in recent years. It will grow from $1.88 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to increasing demand for unbiased medical assessments, growing insurance claim disputes, rising adoption of value-based healthcare, expansion of healthcare quality monitoring, and increasing regulatory compliance requirements.

The independent medical review service market size is expected to see rapid growth in the next few years. It will grow to $3.34 billion in 2030 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to rising adoption of telehealth and remote review services, growing need for cost-effective healthcare dispute resolution, increasing integration of advanced data analytics, expansion of healthcare digitalization, and growing awareness about patient rights and transparency. Major trends in the forecast period include technology advancements in remote medical review platforms, innovations in clinical decision support systems, developments in healthcare data management, research and developments in artificial intelligence-assisted case evaluation, and advancements in cybersecurity and privacy solutions for healthcare data.

The rising demand for impartial assessment of complex medical cases is anticipated to drive the growth of the independent medical review service market in the coming years. Unbiased evaluation involves the objective review of medical decisions, treatment plans, and insurance claim disputes by an independent third-party medical expert to ensure fairness and appropriate patient care. The growing need for unbiased evaluations is driven by increasing complexity in healthcare treatments and the wider adoption of independent dispute resolution processes mandated by regulations to safeguard patients and address disagreements between providers and payers. Independent medical review services support this development by providing objective evaluations that aid dispute resolution, strengthen regulatory compliance, and maintain quality standards across healthcare systems. For example, in April 2025, according to the California Division of Workers’ Compensation annual report, Health Systems, LLC, a US-based provider of Pharmacy Benefit Management (PBM) and Ancillary Benefits Management (ABM), reported that the number of independent medical review applications received rose to 199,651 in 2024, representing a 14.07% increase from 2023, while the number of final determinations issued increased by 8.29% year over year. Consequently, the growing demand for unbiased evaluation of complex medical cases is contributing to the expansion of the independent medical review service market.

The growing complexity of healthcare insurance coverage decisions is also expected to support the growth of the independent medical review service market going forward. This complexity refers to the increasing volume of plan-specific policies, prior authorization requirements, and evidence-based criteria that determine whether medical treatments are approved or denied. It is driven by escalating healthcare costs, the introduction of advanced and specialized therapies, and tighter payer policies focused on cost containment and utilization management. Independent medical review services address this challenge by offering expert, third-party assessments that evaluate coverage decisions against clinical evidence and established medical guidelines, helping ensure fair and consistent outcomes. For instance, in November 2024, according to the U.S. Government Accountability Office (GAO), a US-based federal oversight agency, Medicare Advantage prior authorization requirements increased across several service categories between 2022 and 2024, leading to a higher number of coverage disputes requiring independent review. This increasing complexity in insurance coverage decisions is thereby driving greater demand for independent medical review services.

Major participants in the independent medical review service market are emphasizing the expansion of federally administered external review services, including the HHS-administered Federal External Review Process, to standardize impartial assessments of adverse benefit determinations, enhance transparency, and safeguard consumer appeal rights. The HHS-administered Federal External Review Process is a government-supervised mechanism that enables individuals whose health plans deny coverage based on medical judgment to request an independent evaluation. It delivers objective review of denials related to medical necessity, appropriateness, level of care, or investigational treatments, while ensuring timely outcomes through standardized submission and response timeframes. For example, in September 2024, the Centers for Medicare & Medicaid Services (CMS), a US-based federal healthcare agency, implemented improvements to the HHS-administered Federal External Review Process. Under these updates, consumers can submit written requests for external review within four months of a denial, insurers must provide all supporting documentation within five business days, and standard external review decisions must be issued within 45 days, with expedited reviews completed within 72 hours for urgent cases.

Major companies operating in the independent medical review service market are Optum IME & Review Services, MCMC LLC, MAXIMUS Federal Services Inc., IME Plus LLC, ReviewMed Inc., CorVel Corporation, MedRisk LLC, MedReview Inc., Paradigm Outcomes LLC, Advanced Medical Reviews Inc., eQHealth Solutions Inc., URAC-Accredited Review Services Inc., Healthcare Resolution Services Inc., AllMed Healthcare Management Inc., Kepro Technologies Pvt. Ltd., ProPeer Resources LLC, Independent Review Inc. (IRI), Physician Review Network LLC, Independent Medical Review Associates (IMRA), California Department of Industrial Relations.

North America was the largest region in the independent medical review service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the independent medical review service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the independent medical review service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the independent medical review service market indirectly by increasing costs of imported it infrastructure, secure data servers, medical imaging systems, and digital review platforms. healthcare providers and review organizations in north america and europe are most affected due to reliance on imported digital and diagnostic technologies, while asia-pacific faces higher software licensing and infrastructure expenses. these tariffs are increasing operational costs and slowing digital upgrades. at the same time, they are encouraging cloud-based deployment, domestic software development, and increased adoption of cost-efficient virtual review models.

An independent medical review (IMR) service is a structured assessment process in which a qualified and impartial medical professional examines disputed medical decisions to determine whether a proposed treatment, denied claim, or healthcare service is medically necessary and appropriate. This service promotes fairness and transparency in healthcare decision-making by delivering objective expert evaluations.

The primary types of independent medical review services include prior authorization reviews, utilization reviews, peer reviews, independent evaluations, and disability claim reviews. Prior authorization reviews determine whether proposed treatments are medically necessary before approval. Services may be delivered onsite or remotely. Medical areas include orthopedics, oncology, cardiology, neurology, mental health, and internal medicine. Applications include treatment disputes, coverage denials, disability reviews, investigational treatment assessments, and quality of care disputes, serving healthcare providers, legal firms, employers, governments, and networks.

The independent medical review (IMR) service market includes revenues earned by entities that provide impartial medical case evaluations, medical necessity assessments, appeals review services, legal and insurance claim support services, and healthcare quality audit services. The market value includes the value of related goods sold by the service provider or integrated within the service offering. Only goods and services traded between organizations or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.